Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches (CRUZA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01740219
Recruitment Status : Completed
First Posted : December 4, 2012
Last Update Posted : June 20, 2019
Sponsor:
Collaborator:
University of Massachusetts, Boston
Information provided by (Responsible Party):
Jennifer Allen, Dana-Farber Cancer Institute

Brief Summary:
This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.

Condition or disease Intervention/treatment Phase
Cancer Behavioral: Capacity Enhancement Behavioral: Standard Dissemination Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 348 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Promoting the Utilization of Cancer Early Detection Methods Among Latinos in Church: a Faith-based Approach
Actual Study Start Date : September 2011
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013

Arm Intervention/treatment
Experimental: Capacity Enhancement Behavioral: Capacity Enhancement
Churches in the Capacity Enhancement intervention will be invited to work with CRUZA staff over the course of a three month intervention to implement health promotion activities in their church and participate in capacity-building educational workshops. Participants may also receive technical assistance from Health Educators in order to implement their cancer education activities.

Active Comparator: Standard Dissemination Behavioral: Standard Dissemination
Churches in the Standard Dissemination arm will receive program materials with information about cancer prevention/early detection and health resources.




Primary Outcome Measures :
  1. Implementation [ Time Frame: 3-months ]
    Number and types of interventions offered



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Parishes eligible for the Randomized trial are those that are: Roman Catholic, located in Massachusetts, offer religious services in Spanish, and have taken part in the organizational survey.

Exclusion Criteria:

  • Not Roman Catholic, not located in Massachusetts, don't offer religious services in Spanish, and have not participated in the organizational survey.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01740219


Locations
Layout table for location information
United States, Massachusetts
University of Massachusetts Boston
Boston, Massachusetts, United States, 02125
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Tufts University
Medford, Massachusetts, United States, 02144
Sponsors and Collaborators
Dana-Farber Cancer Institute
University of Massachusetts, Boston
Investigators
Layout table for investigator information
Principal Investigator: Jennifer D Allen, ScD Dana-Farber Cancer Institute
Principal Investigator: Maria Idali Torres, PhD University of Massachusetts, Boston
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Jennifer Allen, Principal Investigator, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier: NCT01740219    
Other Study ID Numbers: 19674
First Posted: December 4, 2012    Key Record Dates
Last Update Posted: June 20, 2019
Last Verified: June 2019
Keywords provided by Jennifer Allen, Dana-Farber Cancer Institute:
Health promotion
Religion and medicine
Hispanic Americans
Randomized controlled trial
Program evaluation
Neoplasms/prevention & control
Mass screening
Female
Male
Preventive Health Services/methods
Adult
Organizations